Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02728531
Recruitment Status : Active, not recruiting
First Posted : April 5, 2016
Last Update Posted : May 19, 2020
Sponsor:
Information provided by (Responsible Party):
Washington University School of Medicine